(Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced it has been awarded a national group purchasing agreement for Cardiac Rhythm Management ...
In the control group, five of 19 patients developed a positive impingement test at 1 month ... pain and disability occurs often following cardiac rhythm management device implantation.
Cardioversion is a procedure that returns an abnormal heart rhythm to normal. It's used when you have an arrhythmia, which means your heart is beating too fast or irregularly. Cardioversion can be ...